Sihuan Pharmaceutical Holdings Stock Five Year Return
Sihuan Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Sihuan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Sihuan Pink Sheet. The fundamental analysis module provides a way to measure Sihuan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sihuan Pharmaceutical pink sheet.
Sihuan |
Sihuan Pharmaceutical Holdings Company Five Year Return Analysis
Sihuan Pharmaceutical's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Sihuan Pharmaceutical Holdings has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Sihuan Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sihuan Pharmaceutical's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sihuan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sihuan Pharmaceutical by comparing valuation metrics of similar companies.Sihuan Pharmaceutical is currently under evaluation in five year return category among its peers.
Sihuan Fundamentals
Return On Equity | -0.0487 | |||
Return On Asset | -4.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0) % | |||
Current Valuation | 506.36 M | |||
Shares Outstanding | 9.33 B | |||
Shares Owned By Insiders | 55.02 % | |||
Shares Owned By Institutions | 4.21 % | |||
Price To Earning | 8.75 X | |||
Price To Book | 0.81 X | |||
Price To Sales | 0.41 X | |||
Revenue | 3.29 B | |||
Gross Profit | 2.45 B | |||
EBITDA | 914.73 M | |||
Net Income | 416.51 M | |||
Cash And Equivalents | 5.25 B | |||
Cash Per Share | 0.56 X | |||
Total Debt | 844.75 M | |||
Debt To Equity | 0.14 % | |||
Current Ratio | 2.43 X | |||
Book Value Per Share | 0.78 X | |||
Cash Flow From Operations | 665.29 M | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 3.9 K | |||
Beta | 0.8 | |||
Market Capitalization | 1.2 B | |||
Total Asset | 14.5 B | |||
Retained Earnings | 5.54 B | |||
Working Capital | 4.66 B | |||
Current Asset | 6.17 B | |||
Current Liabilities | 1.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Net Asset | 14.5 B | |||
Last Dividend Paid | 0.014 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |